There's this special gene called hERG that makes a protein called Kv11.1. This protein is like a boss for a channel that helps control the heartbeat. It sends out a special current that helps the heart do its job better. Now, more and more new drugs are getting approved, and it's expected that this will increase the demand for screenings related to hERG.
In 2018, a fancy center called the Center for Drug Evaluation and Research (CDER) said that about 59 new drugs got the green light to be sold. Fast forward to 2021, and the number was a bit less, around 50 new drugs. But, still, it's a good number of new drugs getting approved. This increase in the approval of new drugs is going to help a process called drug discovery. This process is like finding new ways to make medicines, and hERG screening is part of it. It's like a helper that makes sure new drugs won't mess up the heartbeat.
MORE SPENDING ON HEALTHCARE
People around the world are spending more money on their health. In 2021, the World Health Organization (WHO) said that global spending on health went up by 6% in low- and middle-income countries and 4% in high-income countries. This means more money is being used for healthcare. And guess what? This increase in healthcare spending is also helping the hERG screening market grow.
So, in simple words, more and more new drugs are getting approved, and this is making a special screening process like hERG screening more important. This process helps make sure these new drugs won't cause any trouble with the heartbeat. Also, people worldwide are spending more on staying healthy, and this is contributing to the growth of the hERG screening market. It's like making sure our hearts stay happy and healthy when we use new medicines.
Covered Aspects:Report Attribute/Metric | Details |
---|---|
Market Opportunities | Untapped regional markets |
Market Dynamics | Increasing novel drug approvals and the growing prevalence of heart diseases |
ยฉ 2025 Market Research Future ยฎ (Part of WantStats Reasearch And Media Pvt. Ltd.)